Structure
Clofibrate is a fibrate derivative with a benzofurazan core structure, characterized by two chlorine atoms and a carboxylic acid group.
Chemical Formula: C₁₄H₁₉Cl₂N₃O₄S
Mode of Action
PPAR-α Agonist: Activates peroxisome proliferator-activated receptor alpha (PPAR-α), regulating lipid metabolism.
Triglyceride Reduction: Enhances the oxidation of fatty acids, leading to decreased triglyceride levels.
HDL-C Increase: Increases high-density lipoprotein cholesterol (HDL-C) levels.
VLDL-C Reduction: Lowers very-low-density lipoprotein cholesterol (VLDL-C) levels by reducing hepatic secretion.
Uses of Clofibrate
Hypertriglyceridemia: Lowers elevated triglyceride levels in the blood.
Dyslipidemia: Manages abnormal lipid profiles by reducing total cholesterol and LDL-C levels.
Prevention of Atherosclerosis: Reduces the risk of atherosclerotic cardiovascular diseases by improving lipid profiles.